HOME >> MEDICINE >> NEWS
Treatment response to Aricept® (donepezil hydrochloride) not predicted by Apolipoprotein E4 genotype or gender

WASHINGTON, D.C. 11 July, 2000 -- Aricept® (donepezil hydrochloride) demonstrated beneficial effects on cognition and global function over the course of one year in a double-blind, placebo-controlled, multinational study in patients with mild to moderate Alzheimer's disease (AD). In this study, treatment response was not predicted by Apolipoprotein E4 (ApoE4) genotype and/or gender, according to data presented today at the World Alzheimer Congress in Washington D.C.

ApoE is a lipoprotein that carries cholesterol in the blood. The exact role the ApoE4 allele plays in the pathogenesis of AD or in the memory decline of cognitively impaired elderly is unclear presently. Furthermore, much of the evidence concerning a correlation between ApoE4 copy number and the pathological features of AD (e.g. neuronal plaque density and the appearance of neurofibrillary tangles) is contradictory. It has been suggested that patients carrying an ApoE4 allele may have a more severe cholinergic deficit than those who do not.

"The reports of associations between ApoE4 genotype, gender and response to cholinesterase inhibitor therapy in AD patients are conflicting. In this recently completed study, a secondary analysis showed that the treatment response to ARICEPT®, a cholinesterase inhibitor, was not predicted by ApoE4 genotype and/or gender in patients with mild to moderate AD," says Hilkka Soininen, M.D., Ph.D., University of Kuopio, Kuopio, Finland.

This one-year multinational, double-blind, placebo-controlled study enrolled 286 patients with mild to moderate AD from 28 sites in five Northern European countries (Denmark, Finland, Norway, Sweden and The Netherlands). Patients were randomized to receive either ARICEPT® (n=142; 5 mg/day for 28 days, and then 10 mg/day) or placebo (n=144) for one year. The mean age of the patients enrolled in the study was 72.5 (range: 49-88 years).

Outcomes measures included evaluation of global function (the Gottf
'"/>

Contact: Celeste Torello, Pfizer Inc.
212-733-6471
Porter Novelli
10-Jul-2000


Page: 1 2

Related medicine news :

1. Treatment of cardiac lesions without anaesthesic
2. Treatment guidelines for kids with bipolar disorder published
3. University of Washington joins new Autism Treatment Network to provide better medical services
4. Treatment for brain tumor does not always follow recommendations
5. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
6. Treatment of ductal carcinoma in situ varies widely in United States
7. Treatment options expand for patients with neuropathic pain
8. Treatment interruption shows no benefit in drug-resistant HIV infection
9. Peanut Allergy: Major Advances in Treatment and Education
10. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
11. Treatment helped reduce dose of inhaled corticosteroids while maintaining asthma control

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... SACRAMENTO, Calif. (PRWEB) , ... September 22, 2018 , ... ... however, is the serious health risk that particularly affects older adults – the risk ... Prevention (CDC):, Every second of the day and adult aged 65 and older falls ...
(Date:9/15/2018)... ... September 14, 2018 , ... Today, Mediaplanet announces the ... innovative work being done within rare diseases research, diagnostics, and will highlight what ... rare diseases. , Clay Matthews, Super Bowl-winning linebacker for the ...
(Date:9/13/2018)... ... September 13, 2018 , ... Pulsara is honored to be ... Revenue Cycle Conference on September 19-22 in Chicago. Dr. Woodson, ER Physician and ... as a talk titled, “Your Clinical Communication & Collaboration (CC&C) is Not Enough: Why ...
(Date:9/12/2018)... ... September 13, 2018 , ... Donaldson Plastic Surgery has been ... as Columbus Business First's Fast 50 list of central Ohio's fastest growing businesses. The ... growth rate of 81 percent. It is the only medical practice and plastic surgery ...
(Date:9/7/2018)... ... September 07, 2018 , ... The OSHA ... OSHA authorized OTI Education Center headquartered in Northern California, is shining a spotlight ... have experienced retaliation in response to engaging in activity protected under 22 whistleblower ...
Breaking Medicine News(10 mins):
(Date:9/7/2018)... ... September 07, 2018 , ... Elaine Uonelli, a self-published author ... narrative that shows the author’s experience of encountering with Burkitt lymphoma—an unusual type ... eventful life that revolves around a disease with a lasting impact on human ...
(Date:9/7/2018)... ... ... Pastor and Overseer at The House of Yahweh in Abilene, Texas, has written a new ... is undeniable. , Yisrayl scolds mainstream religions for allowing and even promoting the use of ... great meaning in the Name, and to take that away, shows there is an intentional ...
(Date:9/1/2018)... ... August 31, 2018 , ... New England ... search for a Vice President/ Dean of Academic Affairs. Reporting directly to the ... AA) is the chief academic officer responsible for the faculty and the related ...
Breaking Medicine Technology:
Cached News: